Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Anti-Aging and Autophagy in Prediabetes
NCT03309007Phase 3Completed
- Sponsor
- The University of New Mexico
- Start
- Sep 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in prediabetes and aging (2 arms), sponsored by The University of New Mexico. Primary endpoint: Microtubule-associated protein 1A/1B-light chain 3 at 12 weeks. Started Sep 2017; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prediabetesaging
Beyond the preview
Go deeper on NCT03309007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03309007.